A detailed history of Beaumont Financial Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 10,178 shares of ABBV stock, worth $1.79 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
10,178
Previous 10,202 0.24%
Holding current value
$1.79 Million
Previous $1.56 Million 12.6%
% of portfolio
0.13%
Previous 0.14%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $3,221 - $3,694
-24 Reduced 0.24%
10,178 $1.37 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $27,661 - $35,166
-201 Reduced 1.93%
10,202 $1.56 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $297,746 - $369,420
2,256 Added 27.69%
10,403 $1.69 Million
Q4 2021

Feb 07, 2022

SELL
$107.43 - $135.93 $66,284 - $83,868
-617 Reduced 7.04%
8,147 $1.1 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $744 - $845
-7 Reduced 0.08%
8,764 $945,000
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $83,326 - $92,830
792 Added 9.93%
8,771 $987,000
Q1 2021

May 04, 2021

SELL
$102.3 - $112.62 $45,932 - $50,566
-449 Reduced 5.33%
7,979 $863,000
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $149,469 - $201,800
-1,857 Reduced 18.06%
8,428 $903,000
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $44,587 - $52,330
519 Added 5.31%
10,285 $901,000
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $193,036 - $258,311
2,631 Added 36.87%
9,766 $959,000
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $5,934 - $8,996
92 Added 1.31%
7,135 $544,000
Q4 2019

Feb 06, 2020

BUY
$72.13 - $90.25 $76,818 - $96,116
1,065 Added 17.82%
7,043 $624,000
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $49,754 - $59,818
-790 Reduced 11.67%
5,978 $452,000
Q2 2019

Aug 06, 2019

BUY
$65.7 - $83.98 $20,301 - $25,949
309 Added 4.78%
6,768 $492,000
Q1 2019

May 06, 2019

BUY
$77.14 - $90.79 $14,656 - $17,250
190 Added 3.03%
6,459 $521,000
Q3 2018

Nov 02, 2018

SELL
$88.91 - $98.84 $13,069 - $14,529
-147 Reduced 2.29%
6,269 $593,000
Q2 2018

Aug 06, 2018

SELL
$89.78 - $106.23 $53,778 - $63,631
-599 Reduced 8.54%
6,416 $594,000
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $72,871 - $97,582
792 Added 12.73%
7,015 $664,000
Q4 2017

Feb 05, 2018

BUY
$89.56 - $98.21 $53,109 - $58,238
593 Added 10.53%
6,223 $602,000
Q3 2017

Oct 31, 2017

BUY
$69.85 - $89.22 $977 - $1,249
14 Added 0.25%
5,630 $500,000
Q2 2017

Aug 11, 2017

BUY
N/A
5,616
5,616 $407,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $311B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Beaumont Financial Partners, LLC Portfolio

Follow Beaumont Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.